✦ LIBER ✦

The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: A population-based study in greater Amsterdam

✍ Scribed by O. Visser; R. Bakx; F.A.N. Zoetmulder; C.C. Levering; S. Meijer; J.F.M. Slors; J.J.B. van Lanschot

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 124 KB
Volume: 95
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.20713

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Total mesorectal excision and local recu

Total mesorectal excision and local recurrence: A study of tumour spread in the mesorectum distal to rectal cancer

✍ Dr N. Scott; P. Jackson; T. Al-Jaberi; M. F. Dixon; P. Quirke; P. J. Finan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB 👁 2 views

## Abstract Total mesorectal excision (TME) appears to be associated with a reduced local recurrence rate following surgery for rectal cancer. Of 20 patients with rectal cancer in whom TME was performed, adenocarcinoma was found in the distal mesorectum in four. Distal mesorectal spread often exten

A population-based study evaluating the

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

✍ Daniel Y. C. Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH

Breast carcinoma survival in Europe and

Breast carcinoma survival in Europe and the United States : A population-based study

✍ Milena Sant; Claudia Allemani; Franco Berrino; Michel P. Coleman; Tiiu Aareleid; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND Breast carcinoma survival rates were found to be higher in the U.S. than in Europe. ## METHODS Multiple regression analysis of breast carcinoma survival rates among women diagnosed between 1990 and 1992 was performed using clinical data from population‐based case series